Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at TIDES Europe
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at Festival of
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at CPHI Milan
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at BioProcess International
Yaohai Bio-Pharma to Showcase End-to-End Microbial CRDMO Solutions at BIO International Convention 2026 in San Diego Yaohai Bio-Pharma will attend the upcoming BIO International Convention
NANJING, China, May 28, 2026 — Yaohai Bio-Pharma congratulates its strategic partner, Beijing Northland Biotechnology Co., Ltd. (“Northland Bio”), on the NMPA approval of Donaperminogene
